Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Devonian Health Group, Inc. (TSE:GSD)
TSXV:GSD
Holding TSE:GSD?
Track your performance easily
GSD Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.10 - C$0.35
Previous CloseC$0.16
Volume1.00K
Average Volume (3M)31.40K
Market Cap
C$23.42M
Enterprise ValueC$22.57M
Total Cash (Recent Filing)C$1.00M
Total Debt (Recent Filing)C$150.87K
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Nov 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding148,222,531
10 Day Avg. Volume4,030
30 Day Avg. Volume31,399
Standard Deviation0.30
R-Squared0.04
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)7.71
Price to Sales (P/S)4.71
Price to Cash Flow (P/CF)-17.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Devonian Health Group, Inc. News
PremiumCompany Announcements
Devonian Health Group to Feature in Virtual Investor Event
PremiumCompany Announcements
Devonian Health Spotlights Innovation at Virtual RoadshowPremiumCompany Announcements
Devonian Health’s Revenue Soars with Clinical Advances
PremiumCompany Announcements
Devonian Health Group Joins Renmark Virtual Roadshow
PremiumCompany Announcements
Devonian Health Elevates Founder to Top Roles
PremiumCompany Announcements
Devonian Health Group’s Strong Q2 PerformancePremiumCompany Announcements
Devonian Health Group Secures Fresh CapitalPremiumCompany Announcements
Devonian Health Welcomes New Board ExpertiseOptions Prices
Currently, No data available
---
Ownership Overview
24.49%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
75.51% Public Companies and
Individual Investors
GSD FAQ
What was Devonian Health Group, Inc.’s price range in the past 12 months?
Devonian Health Group, Inc. lowest stock price was C$0.10 and its highest was C$0.35 in the past 12 months.
What is Devonian Health Group, Inc.’s market cap?
Currently, no data Available
When is Devonian Health Group, Inc.’s upcoming earnings report date?
Devonian Health Group, Inc.’s upcoming earnings report date is Nov 26, 2024 which is in 79 days.
How were Devonian Health Group, Inc.’s earnings last quarter?
Devonian Health Group, Inc. released its earnings results on Jun 25, 2024. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Devonian Health Group, Inc. overvalued?
According to Wall Street analysts Devonian Health Group, Inc.’s price is currently Overvalued.
Does Devonian Health Group, Inc. pay dividends?
Devonian Health Group, Inc. does not currently pay dividends.
What is Devonian Health Group, Inc.’s EPS estimate?
Devonian Health Group, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Devonian Health Group, Inc. have?
Devonian Health Group, Inc. has 148,222,530 shares outstanding.
What happened to Devonian Health Group, Inc.’s price movement after its last earnings report?
Devonian Health Group, Inc. reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 42.857%.
Which hedge fund is a major shareholder of Devonian Health Group, Inc.?
Currently, no hedge funds are holding shares in TSE:GSD
---
Devonian Health Group, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Devonian Health Group, Inc.
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It is intended to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. The company's technology platform, The Supra Molecular Complex Extraction, and Stabilization Technology provide a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. The products of the group include botanical pharmaceuticals, Thykamine; and derma-cosmeceutical product, Purgenesis.
---
Technical Analysis
---